Andere talen ESSA Pharma Inc.

Aandelen

EPIX

CA29668H7085

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,26 ^USD	+1,54%		+7,35%	-20,30%

20/05	Top premarket dalers	MT
14/05	ESSA Pharma Inc. rapporteert de winstresultaten voor het tweede kwartaal en de zes maanden eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ESSA Pharma to Present at the Jefferies Global Healthcare Conference	30/05
ESSA Pharma to Present at the Jefferies Global Healthcare Conference	30/05
Top Premarket Decliners	20/05
ESSA Pharma: Fiscal Q2 Earnings Snapshot	14/05
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024	14/05
ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	14/05
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03
Norway's wealth fund pushes for more women on emerging market company boards	06/03
ESSA Pharma : Passive Foreign Investment Company Statement	28/02
ESSA Pharma: Fiscal Q1 Earnings Snapshot	13/02
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	13/02
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	13/02
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	26/01
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	25/01
ESSA Pharma: Fiscal Q4 Earnings Snapshot	12/12
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023	12/12
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	12/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ESSA Pharma Inc.

Aandelen

EPIX

CA29668H7085

Andere talen

Filters